Jazz Pharmaceuticals (JAZZ) Tops Q3 EPS by $2.20, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 234.33 +4.59 (2.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $229.74 | 52 Week High | $160.00 | |||
| Open | $233.23 | 52 Week Low | $95.80 | |||
| Day High | $234.46 | P/E | 43.56 | |||
| Day Low | $228.45 | EPS | $5.38 | |||
| Volume | 632,805 | |||||
